Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. Prognosis for patients with metastatic disease has not improved significantly in the past decades. High-dose chemotherapy (HDC) seems to be an attractive option to treat minimal residual disease in metastatic rhabdomyosarcoma patients.
CITATION STYLE
Admiraal, R., van der Paardt, M., Kobes, J., Kremer, L. C., Bisogno, G., & Merks, J. H. (2010). High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd006669.pub2
Mendeley helps you to discover research relevant for your work.